Atlas Trials

José Antonio Mata Marín

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch José Antonio Mata Marín

RecordFirmDate
Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up (NCT07138144)José Antonio Mata Marín2025-07-12
DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity (NCT07075146)José Antonio Mata Marín2025-05-05
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico (NCT06907056)José Antonio Mata Marín2023-11-09

Track José Antonio Mata Marín automatically

Every clearance here is in the API, with alerts when new ones post.